| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/10/2005 | CA2534387A1 Method for the detection of coliforms and in particular escherichia coli |
| 02/10/2005 | CA2534382A1 Lafora's disease gene |
| 02/10/2005 | CA2534377A1 Method for immunotherapy of tumors |
| 02/10/2005 | CA2534359A1 Apparatus and methods for evaluating the barrier properties of a membrane |
| 02/10/2005 | CA2534336A1 Multiple high-resolution serum proteomic features for ovarian cancer detection |
| 02/10/2005 | CA2534309A1 Method of evaluating compound efficacious in treating obesity by using slc25a10 |
| 02/10/2005 | CA2534305A1 On-chip bioassay method and kit |
| 02/10/2005 | CA2534123A1 Extended primary retinal cell culture and stress models, and methods of use |
| 02/10/2005 | CA2534072A1 Mechanochemical sensor |
| 02/10/2005 | CA2533803A1 Biomarkers of cyclin-dependent kinase modulation |
| 02/10/2005 | CA2533796A1 Crystalline tumor necrosis factor receptor 2 polypeptides |
| 02/10/2005 | CA2533789A1 Epha2 t-cell epitope agonists and uses therefor |
| 02/10/2005 | CA2533667A1 Obesity markers and uses thereof |
| 02/10/2005 | CA2533512A1 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | CA2533102A1 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/10/2005 | CA2532870A1 Use of soluble cd164 in inflammatory and/or autoimmune disorders |
| 02/10/2005 | CA2532742A1 Use of a pak inhibitor for the treatment of a joint disease |
| 02/10/2005 | CA2532509A1 Method and device for deactivating items and for maintaining such items in a deactivated state |
| 02/10/2005 | CA2531684A1 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | CA2531563A1 Analysing biological entities |
| 02/10/2005 | CA2531329A1 Family of 28 kda babesia proteins as vaccines |
| 02/10/2005 | CA2531237A1 Method and device for chemical or biological analysis by a sensor with a monolithic chamber in the form of a multi-microtubular sheaf and a lateral integration measuring transducer |
| 02/10/2005 | CA2531225A1 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | CA2520768A1 Methods of identifying optimal variants of peptide epitopes |
| 02/10/2005 | CA2517908A1 Methods of forming monolayers of phage-derived products and uses thereof |
| 02/10/2005 | CA2515077A1 Cationic anti-microbial peptides and methods of use thereof |
| 02/09/2005 | EP1505395A1 Method for identifying active and/or inactive metobolites; and novel active metabolites |
| 02/09/2005 | EP1505394A1 Platinum complexes for differential mass labelling |
| 02/09/2005 | EP1505393A1 Dry analytical element for high-density lipoprotein cholesterol quantification |
| 02/09/2005 | EP1505392A1 Use of lipase for high-density lipoprotein cholesterol detection |
| 02/09/2005 | EP1505391A1 Method for diagnosing malignant neoplasms |
| 02/09/2005 | EP1505389A1 Personal and environmental fluid sampling apparatus |
| 02/09/2005 | EP1505386A1 Heater-contained gas sensor operation starting method and operation stopping method, and operating method |
| 02/09/2005 | EP1505385A1 Method for diagnosing deterioration of gas sensor and equipment for diagnosing deterioration of gas sensor |
| 02/09/2005 | EP1505179A1 Procedure for identifying weakly binding molecule fragments with ligand properties with the molecule fragments being applied to the crystal as micro-drops of a corresponding solution |
| 02/09/2005 | EP1505161A2 Detection of polymorphisms in Epstein-Barr virus (EBV) DNA for the prediction and detection of EBV-associated cancers |
| 02/09/2005 | EP1505160A2 5'nucleases derived from thermostable DNA polymerase |
| 02/09/2005 | EP1505157A1 Screening assay for anti-bacterial compounds |
| 02/09/2005 | EP1505151A2 Directed evolution method |
| 02/09/2005 | EP1505150A1 Novel proteins and dnas thereof |
| 02/09/2005 | EP1505148A1 Methods of screening for agonistic antibodies |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1505074A1 Histamine receptor h3 ordinary activity mutant and utilization thereof |
| 02/09/2005 | EP1505073A1 Genetically encoded bioindicators of calcium-ions |
| 02/09/2005 | EP1504818A2 Flow-through container for analysing water |
| 02/09/2005 | EP1504714A1 Subscription based biosensor monitoring system and method |
| 02/09/2005 | EP1504419A2 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers |
| 02/09/2005 | EP1504405A1 Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with disease |
| 02/09/2005 | EP1504404A1 Method and apparatus for emission computed tomography using temporal signatures |
| 02/09/2005 | EP1504368A2 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 02/09/2005 | EP1504269A1 Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media |
| 02/09/2005 | EP1504268A2 Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
| 02/09/2005 | EP1504267A1 Solid-phase assisted spectroscopic and spectrometric analysis of complex biopolymer mixtures |
| 02/09/2005 | EP1504266A2 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 02/09/2005 | EP1504265A1 Sandwich assay and kit |
| 02/09/2005 | EP1504264A2 Methods and reagents for conducting multiplexed assays of multiple analytes |
| 02/09/2005 | EP1504263A1 Polyelectrolyte complex (e.g.zwitterionic polythiophenes) with a receptor (e.g. polynucleotide, antibody etc.) for biosensor applications |
| 02/09/2005 | EP1504262A1 Method for investigating the thrombocyte function of the blood |
| 02/09/2005 | EP1504261A2 A t cell subpopulation regulating gut immunity |
| 02/09/2005 | EP1504260A1 Centrifugal cytology system, chamber block and method for the preparation of treated monolayers of sample material |
| 02/09/2005 | EP1504259A1 Method for the determination of changes in a cellular morphological parameter |
| 02/09/2005 | EP1504258A2 Multi-functional microarrays and methods |
| 02/09/2005 | EP1504257A1 Diagnostic test for elemental imbalances |
| 02/09/2005 | EP1504252A1 Systems and methods for blood glucose sensing |
| 02/09/2005 | EP1504247A1 System and methods for rapid and automated screening of cells |
| 02/09/2005 | EP1504241A2 Integratable fluid flow and property microsensor assembly |
| 02/09/2005 | EP1504174A1 Method of analyzing and modifying lubricant in an engine |
| 02/09/2005 | EP1504127A1 Amplification-hybridisation method for detecting and typing human papillomavirus |
| 02/09/2005 | EP1504124A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 02/09/2005 | EP1504123A2 Methods for discovering tumor biomarkers and diagnosing tumors |
| 02/09/2005 | EP1504121A2 Device and method for high-throughput quantification of mrna from whole blood |
| 02/09/2005 | EP1504120A2 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum |
| 02/09/2005 | EP1504118A2 Therapeutic use of selective pde10 inhibitors |
| 02/09/2005 | EP1504116A1 Method and reagent system having an inactivated enzyme |
| 02/09/2005 | EP1504115A1 Method and reagent system having a non-regenerative enzyme-coenzyme complex |
| 02/09/2005 | EP1504114A1 Stochastic sensing through covalent interactions |
| 02/09/2005 | EP1504113A2 Method for producing polymer layers |
| 02/09/2005 | EP1504097A2 Protein interaction system for multisubunit complexes |
| 02/09/2005 | EP1504094A2 Peptide compounds and their use as protease substrates |
| 02/09/2005 | EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/09/2005 | EP1504088A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 02/09/2005 | EP1504085A1 Conductive microplate |
| 02/09/2005 | EP1504030A2 Constitutively translocating cell line |
| 02/09/2005 | EP1504028A2 In vitro bioassay for determining the activity of glycoprotein hormones |
| 02/09/2005 | EP1504024A1 Thermostable and monoconjugatable gold cluster complexes |
| 02/09/2005 | EP1504018A2 Simple catalytic dna biosensors for ions based on color changes |
| 02/09/2005 | EP1503787A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1503661A1 Systems and methods of ph tissue monitoring |
| 02/09/2005 | EP1503660A1 Real time self-adjusting calibration algorithm |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1432825A4 Affinity tag modified particles |
| 02/09/2005 | EP1392417A4 Method and apparatus for detecting cancerous cells using molec ules that change electrophoretic mobility |
| 02/09/2005 | EP1373567A4 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 02/09/2005 | EP1360332A4 Radiative decay engineering |
| 02/09/2005 | EP1339870B1 Methods for external controls for nucleic acid amplification |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1307591A4 Cation mediated triplex hybridization assay |
| 02/09/2005 | EP1287359A4 Coated nanoparticles |